#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Growth hormone deficiency Metastases to central nervous system Von Willebrand's disease Orthostatic hypotension Leiomyosarcoma metastatic Solitary fibrous tumour Soft tissue sarcoma Malignant melanoma Tuberous sclerosis complex Macular telangiectasia Post transplant lymphoproliferative disorder Leukocyte adhesion deficiency type I Antiphospholipid antibodies Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Treatment Pleural mesothelioma malignant – Life with Disease Haemophilia – Treatment Familial haemophagocytic lymphohistiocytosis – Trials in Disease Combined immunodeficiency – Diagnostics Anaplastic thyroid cancer Mantle cell lymphoma stage II – Diagnostics Idiopathic pulmonary fibrosis – Trials in Disease Chordoma Glycogen storage disease type I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ag-946 Carbasalate Calcium Ht-29-A Pentosan Polysulfate Sodium Lurbinectedin Bay 3018250 Ropivacaine Hydrochloride VG801-2 INOBRODIB Cobolimab Vo659 Allopurinol Sultiame Ofloxacin Dog Epithelium Extract Tecaginlimab Risdiplam Glucose Monohydrate Melphalan Flufenamide Gen1055 More therapies…

    Learn about Your Condition

    Colorectal cancer stage II Oesophageal cancer metastatic Arginase deficiency Persistent depressive disorder Endocarditis Invasive breast carcinoma Androgenetic alopecia Post procedural oedema Pancreatic fistula Narcolepsy Vomiting Cytokine release syndrome Ear discomfort Colour blindness Vitamin D deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Juvenile psoriatic arthritis

  • Study on the Effects of Risankizumab and Adalimumab in Children with Active Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Risankizumab
    France Germany Italy Poland Spain

  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Study on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    France Germany Poland Spain

  • Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ustekinumab
    • Guselkumab
    Denmark France Germany Italy The Netherlands Poland +1

  • Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Ixekizumab
    • Adalimumab
    Belgium Czechia France Germany Italy The Netherlands +1

  • Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Ustekinumab
    Belgium France Germany Hungary Italy Poland +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!